{
    "id": 31823,
    "fullName": "CD4 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CD4 positive indicates the presence of the CD4 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 920,
        "geneSymbol": "CD4",
        "terms": [
            "CD4",
            "CD4mut"
        ]
    },
    "variant": "positive",
    "createDate": "12/18/2019",
    "updateDate": "12/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19565,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CD4CAR-expressing natural killer cells induced tumor cell lysis when co-cultured with a CD4-positive peripheral T-cell lymphoma cell line in culture, and reduced tumor burden and increased survival in a cell line xenograft model (PMID: 29348865).",
            "molecularProfile": {
                "id": 34220,
                "profileName": "CD4 positive"
            },
            "therapy": {
                "id": 9084,
                "therapyName": "CD4CAR",
                "synonyms": null
            },
            "indication": {
                "id": 50749,
                "name": "peripheral T-cell lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17177,
                    "pubMedId": 29348865,
                    "title": "Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29348865"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19570,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CD4CAR-expressing natural killer cells induced tumor cell lysis when co-cultured with a CD4-positive T-cell acute lymphoblastic leukemia cell line in culture (PMID: 29348865).",
            "molecularProfile": {
                "id": 34220,
                "profileName": "CD4 positive"
            },
            "therapy": {
                "id": 9084,
                "therapyName": "CD4CAR",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17177,
                    "pubMedId": 29348865,
                    "title": "Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29348865"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19569,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CD4CAR-expressing natural killer cells induced tumor cell lysis when co-cultured with a CD4-positive acute promyelocytic leukemia cell line in culture (PMID: 29348865).",
            "molecularProfile": {
                "id": 34220,
                "profileName": "CD4 positive"
            },
            "therapy": {
                "id": 9084,
                "therapyName": "CD4CAR",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17177,
                    "pubMedId": 29348865,
                    "title": "Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29348865"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19568,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CD4CAR-expressing natural killer cells induced tumor cell lysis when co-cultured with a patient-derived CD4-positive pediatric T-cell acute lymphoblastic leukemia cell line in culture (PMID: 29348865).",
            "molecularProfile": {
                "id": 34220,
                "profileName": "CD4 positive"
            },
            "therapy": {
                "id": 9084,
                "therapyName": "CD4CAR",
                "synonyms": null
            },
            "indication": {
                "id": 80145,
                "name": "childhood T-cell acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17177,
                    "pubMedId": 29348865,
                    "title": "Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29348865"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19567,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CD4CAR-expressing natural killer cells induced tumor cell lysis when co-cultured with a patient-derived CD4-positive cutaneous T cell lymphoma cell line in culture (PMID: 29348865).",
            "molecularProfile": {
                "id": 34220,
                "profileName": "CD4 positive"
            },
            "therapy": {
                "id": 9084,
                "therapyName": "CD4CAR",
                "synonyms": null
            },
            "indication": {
                "id": 60061,
                "name": "cutaneous T cell lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17177,
                    "pubMedId": 29348865,
                    "title": "Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29348865"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34220,
            "profileName": "CD4 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}